Topically Applied Midodrine, 0.2%, an Α1-Agonist, for the Treatment of Erythromelalgia
JAMA Dermatology - United States
doi 10.1001/jamadermatol.2015.0511
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
American Medical Association (AMA)